arrow
C

Claus Garbe

University Hospital of Tuebingen
H指数:130
被引数:8.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years

原发性黑色素瘤假阴性诊断患者的生命损失年数。一项涉及9063例患者、为期28年的德国中央恶性黑色素瘤登记研究的回顾性研究

2026-07-020
OAAI
Characteristics and Quality of Life of Nine-Year Survivors with Metastatic Melanoma treated with Pembrolizumab beyond second-line therapy

九例接受帕博利珠单抗二线后治疗转移性黑色素瘤的五年生存者的特征与生活质量

2025-11-290
PRE
Messages for ultraviolet-radiation protection to fair-skinned populations

关于紫外线防护的信息,面向肤色较浅的人群

2025-11-060
OAAI
Adjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and BRAF V600 mutation

辅助抗PD-1疗法可改善具有高肿瘤突变负荷和BRAF V600突变的IIIC-IV期黑色素瘤患者的黑色素瘤特异性生存率。

2025-08-130
OA
Neoadjuvant Intralesional Targeted Immunocytokines (Daromun) in Stage III Melanoma.

新辅助病灶内靶向免疫细胞因子(Daromun)在III期黑色素瘤中的应用。

2025-07-070
PREAI
An update on access to novel treatment for metastatic melanoma in Europe - A 2024 survey of the European melanoma registry and the European association of dermato-oncology

关于欧洲转移性黑色素瘤新型治疗方法可及性的最新进展——2024年欧洲黑色素瘤登记系统与欧洲皮肤肿瘤学会联合调查

2025-02-011
PRE
Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

皮肤黑色素瘤:ESMO 临床实践指南(用于诊断、治疗和随访)

2025-01-0111
PRE
A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine
2024-08-113
OAAI
Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by experts
2024-07-030
OAAI
Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them.

皮肤癌是皮肤白皙人群中最常见的癌症,但我们可以预防它们。

2024-06-018
OA
Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A singleinstitutional cohort study

接受前哨淋巴结活检的原发性皮肤黑色素瘤患者的组织病理学消退与良好的生存率相关,转移后,免疫检查点抑制剂治疗可改善无进展生存率: 一项单机构队列研究

2024-04-012
OAAI
Analysis of biomarker and outcomes data: 7-year update from COLUMBUS
2024-03-220
PRE
European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization on behalf of European Association of Dermato-Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Européenne des Médecins Spécialistes)
2024-03-074
PRE
Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy

增强MEK抑制剂在BRAF野生型黑色素瘤中的功效: 双硫仑联合治疗的协同作用

2024-01-232
OAAI